Acta Neurol Belg. 2019 Jul 26. doi: 10.1007/s13760-019-01194-4. [Epub ahead of print] Redon S1, Elzière M2, Lambert I3, Donnet A4,5. KEYWORDS: Benign paroxysmal vertigo; Cyclic vomiting syndrome; Episodic syndrome; Vestibular migraine PMID: 31350731 DOI: 10.1007/s13760-019-01194-4
Spinal cord stimulation for chronic refractory pain: Long-term effectiveness and safety data from a multicentre registry.
Eur J Pain. 2019 May;23(5):1031-1044. doi: 10.1002/ejp.1355. Epub 2019 Apr 1. Brinzeu A1, Cuny E2, Fontaine D3,4, Mertens P1, Luyet PP5, Van den Abeele C5, Djian MC6; French SCS Study Group. Abstract BACKGROUND: Spinal cord stimulation (SCS) is an established
Management of patients presenting with generalized musculoskeletal pain and a suspicion of Lyme disease.
Med Mal Infect. 2019 Mar;49(2):157-166. doi: 10.1016/j.medmal.2019.01.008. Epub 2019 Feb 11. Ranque-Garnier S1, Eldin C2, Sault C1, Raoult D3, Donnet A1. Abstract Lyme disease is caused by bacteria of the B. burgdorferi sensu lato complex, and can give polymorphic clinical manifestations that
Migraine-Associated TRESK Mutations Increase Neuronal Excitability through Alternative Translation Initiation and Inhibition of TREK.
Neuron. 2019 Jan 16;101(2):232-245.e6. doi: 10.1016/j.neuron.2018.11.039. Epub 2018 Dec 17. Royal P1, Andres-Bilbe A2, Ávalos Prado P1, Verkest C3, Wdziekonski B1, Schaub S4, Baron A5, Lesage F3, Gasull X2, Levitz J6, Sandoz G7. Abstract It is often unclear why some
QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France.
Curr Med Res Opin. 2019 Mar;35(3):417-426. doi: 10.1080/03007995.2018.1558850. Epub 2019 Jan 7. Lantéri-Minet M1,2, Perrot S3. Abstract OBJECTIVE: To describe the characteristics of patients treated with the capsaicin 8% patch, prescribing conditions, long-term effects of repeat treatment on pain intensity
First Bite Syndrome After Trigeminal Radiosurgery: Case Report and Pathophysiology.
Headache. 2018 Nov;58(10):1680-1681. doi: 10.1111/head.13449. Epub 2018 Nov 15. Redon S1, Graillon N2, Régis J3, Donnet A4.
Effects of systemic inhibitors of Acid-Sensing Ion Channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine.
Br J Pharmacol. 2018 Nov;175(21):4154-4166. doi: 10.1111/bph.14462. Epub 2018 Sep 22. Verkest C1,2,3, Piquet E3,4, Diochot S1,2,3, Dauvois M1, Lanteri-Minet M3,4,5, Lingueglia E1,2,3, Baron A1,2,3. Abstract BACKGROUND AND PURPOSE: Acid-sensing ion channels (ASICs) are neuronal proton sensors emerging as potential
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
Lancet. 2018 Nov 24;392(10161):2280-2287. doi: 10.1016/S0140-6736(18)32534-0. Epub 2018 Oct 22. Reuter U1, Goadsby PJ2, Lanteri-Minet M3, Wen S4, Hours-Zesiger P5, Ferrari MD6, Klatt J5. Abstract BACKGROUND: A substantial proportion of patients with migraine does not respond to, or cannot tolerate,
My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed.
J Headache Pain. 2018 Nov 27;19(1):115. doi: 10.1186/s10194-018-0946-z. Martelletti P1,2, Schwedt TJ3, Lanteri-Minet M4, Quintana R5, Carboni V6, Diener HC7, Ruiz de la Torre E8, Craven A9, Rasmussen AV10, Evans S11, Laflamme AK12, Fink R12, Walsh D13, Dumas P14, Vo
Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine.
Front Mol Neurosci. 2018 Jul 9;11:232. doi: 10.3389/fnmol.2018.00232. eCollection 2018. Dhifallah S1, Lancaster E2, Merrill S2, Leroudier N1, Mantegazza M1, Cestèle S1. Author information Abstract The SCN1A gene encodes for the voltage-dependent Nav1.1 Na+ channel, an isoform mainly expressed in